✦ LIBER ✦

Intensity-modulated Radiotherapy (80 Gy) in Low, Intermediate, and High-risk Prostate Cancer: Factors Influencing Relapse and Toxicity

✍ Scribed by Charissoux, M.; Llacer Moscardo, C.; Thezenas, S.; Fenoglietto, P.; Ailleres, N.; Segui, B.; Rebillard, X.; Hay, M.; Dubois, J.; Azria, D.

Book ID: 108149056
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 42 KB
Volume: 75
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2009.07.1465

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Toxicity Assessment of Pelvic Intensity-

Toxicity Assessment of Pelvic Intensity-Modulated Radiotherapy With Hypofractionated Simultaneous Integrated Boost to Prostate for Intermediate- and High-Risk Prostate Cancer

✍ Robert McCammon; Kyle E. Rusthoven; Brian Kavanagh; Sherri Newell; Francis Newma 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 282 KB

Acute Toxicity in High-Risk Prostate Can

Acute Toxicity in High-Risk Prostate Cancer Patients Treated With Androgen Suppression and Hypofractionated Intensity-Modulated Radiotherapy

✍ Nadeem Pervez; Cormac Small; Marc MacKenzie; Don Yee; Matthew Parliament; Sunita 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 318 KB

Urethral toxicity vs. cancer control—Les

Urethral toxicity vs. cancer control—Lessons to be learned from high–dose rate brachytherapy combined with intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer

✍ Pirus Ghadjar; Cyrill A. Rentsch; Bernhard Isaak; Frank Behrensmeier; George N. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 360 KB

High-dose-rate intensity modulated brach

High-dose-rate intensity modulated brachytherapy with external-beam radiotherapy improves local and biochemical control in patients with high-risk prostate cancer

✍ Pedro J. Prada; Herminio González; José Fernández; Pedro Bilbao 📂 Article 📅 2008 🏛 Springer Milan 🌐 Spanish ⚖ 108 KB

Toxicity and early treatment outcomes in

Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy

✍ Pirus Ghadjar; Tamara Keller; Cyrill A. Rentsch; Bernhard Isaak; Frank Behrensme 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 223 KB